Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
08/2005
08/31/2005CN1660790A Microwave method for synthesizing 2, 6-ramification of dicyan aniline
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/30/2005US6936720 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
08/25/2005WO2005021515A3 Inhibitors of phosphodiesterase type-iv
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/24/2005EP1565422A1 Vitamin d receptor modulators
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005CN1657524A Substituted azole compounds and their preparation and application
08/18/2005US20050182113 Method for preparing diaryl-substituted isoxazole compounds
08/18/2005US20050182032 vitamin D3 antagonist activity; treating Paget's disease, bone diseases, hypercalcemia or osteoporosis; e.g. 1 alpha,25-dihydroxyvitamin D3-26 23-lactam, N-(p-methoxy)benzyl
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1563300A2 Diagnostic method for celiac sprue
08/17/2005EP1562915A1 Farnesoid x receptor agonists
08/17/2005EP1562914A1 Nitric oxide releasing selective cyclooxygenase-2 inhibitors
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin
08/17/2005CN1214790C Method for preparing isoxazole substituted composition for treating inflammation
08/16/2005US6930208 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones
08/11/2005WO2005054174A3 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
08/11/2005WO2005007635A3 Combretastatin derivatives with cytotoxic action
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653037A Substituted tetracycline compounds
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005US20050171358 Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide
08/04/2005US20050171173 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171104 Novel thyroid receptor ligands
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649498A 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/02/2005US6924312 Taxol enhancer compounds
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068442A2 Isoxazole derivatives and their use as cyclooxygenase inhibitors
07/28/2005WO2005068432A1 Malononitrile compound as pesticides
07/28/2005WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005US20050165020 5-(2,6-Difluorobenzyloxymethyl)-5-methyl-3-(3-propylisoxazol-5-yl)-4,5-dihydroisoxazole, used as preemergence or postemergence plant growth regulators
07/28/2005US20050164120 High photosensitivity, visible laser recording materials; comprised of novel squarylium compound metal complexes, free radical generators and monomers
07/27/2005EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases
07/27/2005EP1556330A2 Phenyl compounds
07/27/2005EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas
07/27/2005CN1646518A 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
07/27/2005CN1646122A A medicament for preventing and/or treating chronic rejection
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/26/2005CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives
07/21/2005WO2005066164A1 Opioid receptor antagonists
07/21/2005WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators
07/21/2005WO2005066143A2 Benzo[d]isoxazol-3-ol daao inhibitors
07/21/2005WO2005066138A1 Substituted heterocyclic amides having a fungicidal effect
07/21/2005WO2005065684A1 Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
07/21/2005WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
07/21/2005US20050159466 Production method of isoxazolidinedione compound
07/21/2005US20050159465 3-(4-Hydroxy-2-methylphenyl)-1,2-benzisoxazol-6-ol; estrogen receptor modulators; ability to compete with 17 beta -estradiol for both Estrogen Receptor alpha and Estrogen Receptor beta; Estrogen Receptor Selective Agonist Antagonist activity; anticancer, antiinflammatory, anticholesterol
07/21/2005CA2552098A1 Benzo[d]isoxazol-3-ol daao inhibitors
07/21/2005CA2551523A1 Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
07/21/2005CA2549089A1 Opioid receptor antagonists
07/20/2005EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands
07/20/2005EP1066237B1 Processes for preparing intermediates
07/20/2005CN1642953A Process for preparing crystalline form I of cabergoline
07/20/2005CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642926A Crystalline parecoxib sodium
07/20/2005CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
07/20/2005CN1642906A Novel arylamidine derivative or salt thereof
07/20/2005CN1211367C Prostaglandin agonists and their use to treat bone disorders
07/19/2005US6919470 Aryl and heteroaryl sulfonates
07/19/2005US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
07/19/2005US6919329 Microorganisms; bactericides; human and veterinary medicine
07/14/2005WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
07/14/2005WO2005040142B1 Novel keto-oxadiazole derivatives as cathepsin inhibitors
07/14/2005WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050153996 Compounds that modulate ppar activity and methods for their preparation
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 115